Metaplastic breast carcinoma is an aggressive form of invasive breast cancer with histological evidence of epithelial to mesenchymal transition (EMT). However, the defining molecular events are unknown. Here we show that CCN6 (WISP3), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic breast carcinoma. We generated a mouse model of mammary epithelial-specific Ccn6 deletion by developing a floxed Ccn6 mouse which was bred with an MMTV-Cre mouse. Ccn6 fl/fl ;MMTV-Cre mice displayed severe defects in ductal branching and abnormal age-related involution compared to littermate controls. Ccn6 fl/fl ;MMTV-Cre mice developed invasive high grade mammary carcinomas with bona fide EMT, histologically similar to human metaplastic breast carcinomas. Global gene expression profiling of Ccn6 fl/fl mammary carcinomas and comparison of orthologous genes with a human metaplastic carcinoma signature revealed a significant overlap of 87 genes (P = 5 × 10 − 11 ). Among the shared deregulated genes between mouse and human are important regulators of epithelial morphogenesis including Cdh1, Ck19, Cldn3 and 4, Ddr1, and Wnt10a. These results document a causal role for Ccn6 deletion in the pathogenesis of metaplastic carcinomas with histological and molecular similarities with human disease. We provide a platform to study new targets in the diagnosis and treatment of human metaplastic carcinomas, and a new disease relevant model in which to test new treatment strategies.
INTRODUCTION
Metaplastic breast carcinomas constitute approximately 1% of invasive carcinomas and are characterized by histological evidence of epithelial to mesenchymal transition (EMT) towards spindle, squamous, and less frequently heterologous elements including chondroid and osseous differentiation. 1 Metaplastic carcinomas are a subtype of triple negative breast cancer (TNBC) that are poorly responsive to chemotherapy, with high propensity for distant metastasis. 2, 3 Recent comprehensive genomic analyses revealed that metaplastic carcinomas belong to the mesenchymallike subtype of TNBC, with a distinct transcriptional profile than other invasive breast carcinomas. [4] [5] [6] However, the molecular determinants of metaplastic carcinomas needed to inform effective treatments are still incompletely understood.
Metaplasia is the reversible change in which one adult cell type is replaced by another adult cell type. Epithelial cells may undergo metaplasia through EMT, which during tumorigenesis results in the acquisition of molecular and phenotypic changes towards a spindle cell morphology and dysfunctional cell-cell adhesion, leading to invasion and metastasis. 7 Of all human cancers, metaplastic carcinomas provide the clearest evidence of morphological and molecular EMT with deregulation of genes involved in cell adhesion and low expression of claudins. [4] [5] [6] CCN6 (WISP3) is a secreted matricellular protein of the CCN family, which includes six members that play regulatory rather than structural roles in embryonic development, cell attachment and growth. 8 CCN proteins act in a cell and tissue-specific manner primarily through direct binding to cell surface receptors including integrins and by modulating the effect of extracellular growth factors on epithelial cells. [9] [10] [11] [12] [13] [14] Located at 6q21-22, CCN6 was first identified as a novel gene downregulated in the highly aggressive inflammatory breast cancers. 15 We have shown that CCN6 is secreted by ductal epithelial cells in the breast, and that CCN6 downregulation in nontumorigenic breast cells is a robust inducer of EMT and is sufficient to confer growth factor independent survival and resistance to anoikis, a property of metastatic cancer cells. 9, [11] [12] [13] [14] [15] [16] [17] Despite this knowledge, a direct role of CCN6 in breast tumorigenesis and the underlying mechanisms have remained elusive in part due to the lack of a physiologically relevant genetically engineered mouse model.
RESULTS
CCN6 protein is reduced in human metaplastic carcinomas Based on our previous studies showing that CCN6 regulates the transition between epithelial and mesenchymal states in breast cells, we set out to investigate CCN6 expression in breast tissues. Immunohistochemical evaluation revealed that CCN6 level is significantly reduced in spindle metaplastic carcinomas compared to normal breast and invasive ductal carcinomas (Figure 1a ). All normal breast lobules examined, and 67% of invasive ductal carcinomas maintained high levels of CCN6. This distribution was shifted in metaplastic carcinomas, among which 67.9% had low CCN6 expression ( Figure 1b ).
Mammary epithelial specific Ccn6 deletion causes abnormal mammary gland development To directly investigate whether loss of Ccn6 in vivo triggers the development of carcinomas that recapitulate human metaplastic carcinomas, we generated a new model of epithelial cell specific Ccn6 deletion in the mammary gland using Cre/loxp-mediated recombination (Figures 2a and b ). We specifically inactivated the Ccn6 gene in the mammary epithelium, by intercrossing the floxed Ccn6 mice with the MMTV-Cre mice. The offspring were genotyped using primers specific for various Ccn6 alleles (that is, floxed, wild type and deleted) and with primers specific for Cre ( Figure 2c ). We confirmed the presence of Ccn6 deletion in the mammary glands by quantitative reverse transcriptase-PCR and Western blots using whole mammary gland protein extracts, and by immunohistochemistry in mammary gland tissue samples
Our initial characterization studies showed that pre-pubertal (5-week-old) and pubertal (8- To assess the global impact of CCN6 ablation on mammary epithelial cell development in vivo in an unbiased fashion, isolated RNA from 8-week-old virgin Ccn6 fl/fl ;MMTV-Cre mammary glands and littermate controls was subjected to transcriptional profiling. Ccn6 deletion significantly altered the expression of~180 unique transcripts with marked effects noted in gene ontologies associated with extracellular signaling, matrix-associated functions and mammary gland lobule development including Bmp8a, Acta1, Cxcl13 and Dmbt1 (Figure 3g , Supplementary Figures 4A-C) . Together, the results indicate that Ccn6 is required for branching morphogenesis and proper development of the mammary ductal epithelium in virgin mice.
Deletion of Ccn6 in the mammary epithelium results in abnormal age-related involution In humans, delayed age-related mammary gland involution has been associated with increased risk for breast cancer. 18, 19 We found evidence of abnormal age-related involution in virgin Ccn6 fl/fl ;MMTV-Cre mice compared to controls. As expected, while at 8 months of age, one of four (25%) control mice had foci of brown adipose tissue, all Ccn6 fl/fl ;MMTV-Cre mice examined had residual brown adipose tissue in the mammary glands ( Figure 5B , Table 1 ). Distant metastasis developed in 6 of 13 (46.2%) tumor-bearing Ccn6 fl/f ;MMTV-Cre mice, 5 to the lungs, and 1 to the soft tissues of the neck, compared to none of the Ccn6 wt/wt ;MMTV-Cre control mice. To investigate the effect of Ccn6 deletion in metastasis in greater detail, we crossed Ccn6 fl/fl ;MMTV-Cre mice with polyoma middle-T antigen (PyMT)-MMTV mice. PyMT-MMTV mice uniformly develop multifocal mammary tumors with a high incidence of pulmonary metastasis. 20 Despite no differences in primary mammary tumor volume, female virgin Ccn6 fl/fl ;MMTV-Cre/PyMT mice showed a significant increase in the number of expression profiles of metaplastic carcinomas with profiles of all other breast cancers. 5 By directly comparing the relative expression ratio of orthologous genes between human and mouse, we found that Ccn6 fl/fl ;MMTV-Cre tumors exhibit similarities with the gene expression activity of human metaplastic carcinomas. Of the 602 orthologous genes in the human metaplastic carcinoma signature, there were 87 (14.4%) shared genes concordantly up-or downregulated with human metaplastic carcinomas (Fisher's exact test P = 5 × 10 − 11 , Figures 6a and b ).
In Gene Ontology analyses, the 87 shared orthologous genes fell into several functional groups. The top five enriched biological processes were morphogenesis of an epithelium, embryo development, lateral plasma membrane, cellular amino acid metabolic process and very long chain fatty acid catabolic process ( Table 2 , Supplementary Figure 5 ). Ccn6 fl/fl ;MMTV-Cre tumors exhibited downregulated expression of Cldn3, Cldn5, Cdh1, Krt19, previously reported in human metaplastic carcinomas. [4] [5] [6] Significantly, Ddr1, Fzd3, Elf3, Stat5b and Foxa1 are among the shared downregulated genes, while Wnt10a, Hmga2, Hbegf and Edil3 are among shared upregulated genes (Figure 6b ). While these genes are important for normal epithelial homeostasis and have been implicated in carcinogenesis, they have not been previously considered in the pathogenesis of metaplastic carcinoma.
In daily pathology practice, the diagnosis of metaplastic carcinoma is supported by detection of a combination of epithelial and mesenchymal proteins. 6, [21] [22] [23] [24] Ccn6 fl/f ;MMTV-Cre mice tumors had a protein expression profile similar to human metaplastic carcinoma characterized by negative estrogen receptor and human epidermal growth factor receptor 2, ERBB2 (HER-2/neu) expression, reduced expression of epithelial markers E-cadherin and cytokeratin-18, and increased expression of the mesenchymal markers vimentin, and the human metaplastic carcinoma markers CD10 and p63 21, 25, 26 (Figure 6c ). Taken together, these data document that Ccn6 deletion in the mammary gland epithelium is sufficient to induce carcinomas with histological, immunophenotypic and transcriptomic features that recapitulate human spindle metaplastic carcinomas. 
DISCUSSION
Metaplastic carcinomas, and in particular those with spindle histopathology, are less responsive to chemotherapy than other TNBC. 22, 27 Elucidation of the molecular underpinnings of this unusual but aggressive type of breast cancer is necessary to develop effective therapeutic strategies. Our previous identification of Ccn6 frame shift mutations in human metaplastic carcinoma tissues 28 coupled with the observation that CCN6 expression is reduced or absent in clinical samples of metaplastic carcinoma raised the suspicion that Ccn6 may be causally involved in their pathogenesis rather than solely serve as a marker for these tumors. Our results demonstrate that genetic ablation of Ccn6 in the mammary epithelium of mice induces the development of invasive tumors that recapitulate human metaplastic spindle carcinomas on their histopathology, transcriptional activity and biological behavior. Ample mechanistic and functional data support the importance of the process of EMT in human tumorigenesis; however, direct identification of cancer cells undergoing EMT in clinical cancer tissue samples has been challenging. 29 Metaplastic carcinomas of the breast and other organs are the only human malignancies with overt EMT consisting of spindle cells and mesenchymal-like components, loss of epithelial and gain of mesenchymal marker proteins, and a distinctive transcriptional profile rich in genes involved in EMT. [4] [5] [6] CCN proteins are secreted extracellular matrix associated proteins that regulate stromal-epithelial cross-talk to influence angiogenesis, cell proliferation, invasion, adhesion and other important cell functions in a context-dependent manner. [9] [10] [11] [12] [13] Ccn6 fl/fl mammary tumors CCN6 mutations were reported in patients with progressive pseudorheumatoid dysplasia, and deregulated expression of CCN6 was found in colon and breast cancer. 15, 30, 31 However, global Ccn6 deletion in transgenic mice revealed no discernible skeletal phenotype. 32 In breast cancer, we have demonstrated that CCN6 regulates the transition between epithelial and mesenchymal states in vivo and in vitro. 9, 11, 33, 34 CCN6 knockdown in nontumorigenic breast cells induces a spindle and invasive phenotype with inhibited expression of E-cadherin and cytokeratin, and upregulation of vimentin and EMT transcription factors. 9, 11 In contrast, CCN6 overexpression in breast cancer cells reduces invasion and metastasis in xenograft models, and leads to a mesenchymal to epithelial transition. 12, 33, 34 However, proof that Ccn6 deficiency results in mammary tumor development and the relevance of these data to human metaplastic carcinomas was unknown. The mammary epithelial cell-specific Ccn6 knockout model developed here provides direct demonstration of an essential role for CCN6 in the pathogenesis of mammary carcinomas with overt EMT. During mammary gland development, pre-pubertal and nulliparous adult Ccn6 fl/fl ;MMTV-Cre mice exhibit fewer mammary ducts and a hypoplastic breast epithelium with defective developmental patterns and reduced mitosis compared to littermate controls. The restricted development of the mammary glands of Ccn6 fl/fl ;MMTV-Cre mice highlights a role for Ccn6 in mammary gland morphogenesis and may have implications for tumorigenesis. A similar phenotype has been reported after deletion of classical tumor suppressors including Brca1 and Brca2. [35] [36] [37] Because Ccn6-related tumorigenesis is characterized by an initial growth disadvantage it is not unexpected that tumor formation occurs after a long latency, albeit with high frequency, as observed in Brca1 conditional knockout mice. 37 The developmental delay in pre-pubertal Ccn6-deficient mice and the propensity to develop carcinomas in adult life may be linked to the deregulation of gene targets. Transcriptional profiling of Ccn6 deleted versus Ccn6 wild-type pre-pubertal mammary glands uncovered a complex range of deregulated targets, especially those associated with mammary epithelial development. We noted a significant downregulation of Dmbt1, a glycoprotein of the scavenger receptor cysteine-rich family, with roles in immunity and cancer. 38 Dmbt1 was identified as a modifier of susceptibility to mammary tumors in Trp53+/ − BALB/c breast cancer model, 39 and Dmbt1 polymorphisms are associated with increased risk of breast cancer. 40 In contrast with invasive ductal or lobular carcinomas of the breast, metaplastic carcinomas often lack an associated ductal carcinoma in situ component, and its precursors have not been identified in tissue samples. 24 The conditional Ccn6 knockout mice generated here shed light into the histological abnormalities that precede the development of spindle cell metaplastic carcinomas. Virgin Ccn6 fl/fl ;MMTV-Cre mammary glands failed to involute properly with age, as evidenced by abnormal persistence of residual TEBs and brown adipose tissue at 8 months of age, in contrast with the mammary glands of age-matched littermate control mice. Of note, defective age-related involution with persistent brown adipose tissue has been reported in mammary glands from adult Brca1 mutant mice prior to development of poorly differentiated carcinomas. 41 These data are remarkable in light of recent studies showing that defective age-related involution in human mammary glands is significantly associated with increased risk for breast cancer development. 18, 19 Postmenopausal women with delayed agerelated mammary gland involution have a three-fold increased risk of breast cancer compared with women with complete involution. 18, 19 Collectively, our model provides insights into the role of Ccn6 loss during preneoplastic progression and may have clinical implications for preventative strategies.
Our transcriptional profiling studies show that Ccn6 fl/fl ;MMTV-Cre tumors share an 87-gene signature with human metaplastic carcinomas. 5 Among the 87 shared genes (10 up-and 77 are downregulated) are several that have been previously studied as markers of human metaplastic carcinoma including downregulated expression of Cdh1, Cldn3, Cldn4 and Krt19. 5, 21, 24, 42 Also significantly overlapping with human metaplastic carcinomas are novel genes, which have not been previously studied in this context. Among the three top upregulated genes are Hmga2, Igfbp2 and Hbegf. Hmga2 (high mobility group AT-hook 2) was previously reported to promote EMT and metastasis by activating the transforming growth factor β receptor II signaling. 43 Igf2bp2 (p62/IMP2), a member of the family of insulin-like growth factor 2 mRNA binding proteins, promotes breast cancer cell migration and reduces adhesion in TNBC cells. 44 Hbegf (heparin binding epidermal growth factor-like growth factor) induces breast cancer intravasation and metastasis. 45 Among the most significantly downregulated genes shared between Ccn6 fl/fl ;MMTV-Cre tumors and human metaplastic carcinomas are Foxa1, Spint1 and 2 and Ddr1. Foxa1 is an important regulator of the ERα and the androgen receptor, whose silencing increases invasion and induces an aggressive, basal-like breast cancer phenotype. 46 Spint 1 and 2 (hepatocyte growth factor activation inhibitors HAI-1 and HAI-2) are potent matriptase inhibitors reducing invasion and metastasis in TNBC. 47 The Discoidin Domain Receptor 1 (Ddr1), a collagenbinding receptor tyrosine kinase, is associated with worse survival in women with TNBC. 48 Elucidating the functional significance and underlying mechanism of these novel genes, which were previously unconsidered in the context of metaplastic carcinoma, may lead to new diagnostic, prognostic and therapeutic targets. In conclusion, data presented herein establish that mammary epithelial cell loss of Ccn6 triggers the development of spindle metaplastic carcinomas recapitulating human disease. We believe that this mouse model will be useful in understanding how Ccn6 serves its breast cancer suppression function. mammary epithelial-cell specific Ccn6 deletion were generated using the Cre-Lox recombination system. The mouse chromosome 10 sequence of mWisp3 gene was retrieved from the Ensembl database and used as reference. Using genomic DNA from FVB mice as a template, the 5′ homology arm (~5.6 kb), 3′ homology arm (~3.7 kb) and the conditional knockout region (~4.5 kb, containing exons 2 and 3) of the Ccn6 allele were generated by PCR using high fidelity Taq DNA polymerase. These fragments were cloned in the LoxFtNwCD or pCR4.0 vector; aside from the homology arms, the final vector also contained LoxP sequences flanking the conditional KO region (~4.5 kb), Frt sequences flanking the Neo expression cassette (for positive selection of the electroporated embryonic stem (ES) cells), and a DTA expression cassette (for negative selection of the ES cells). The final vector was confirmed by both restriction digestion and end sequencing analysis. For southern blot analysis and identification of the ES positive for homologous recombination with single neo integration, 5′ and 3′ external probes were generated by PCR. Thirty micrograms of NotI-linearized targeting vector DNA was electroporated into FVB ES cells and selected with 200 μg/ml G418 (Gibco, Waltham, MA, USA, #10131-035). The primary ES cell screening was performed with 3′ PCR and distal LoxP PCR. Five potential targeted clones (A9, B7, B8, H1 and H6) were identified from one plate, which were expanded for further analysis. Upon completion of the ES clone expansion, additional Southern confirmation analysis was performed. Based on this analysis, two out of the five expanded clones (B7 and B8) were confirmed for homologous recombination with single neo integration. Flp electroporation was performed on these clones, and subsequent Neo deleted clones were identified and confirmed by PCR upon expansion. Confirmed Neo-deleted ES cell clones were injected into mouse C57BL/6NTac blastocysts and breeding of the male chimeras to wild-type FVB females resulted in germline transmission. Heterozygous Ccn6 fl/wt mice were crossed with MMTV-Cre line A mice on an FVB background (kind gift of Dr Stephen Weiss). Generation of the targeting vector, cloning, electroporation into embryonic stem cells and breeding of chimeras to F1 generation mice was carried out by Taconic Biosciences, Inc. (Salisbury, CT, USA). Ccn6 fl/fl ;MMTV-Cre mice were intercrossed with MMTV-PyMT mice (FVB/n) to generate breeding cohorts. After weaning, female mice were examined twice a week for the development of mammary tumors by palpation. Tumors were then measured once per week until tumors reached 1 cm 3 , after which tumors were measured twice per week until mice were euthanized. Mice were euthanized when tumors reached 2 cm 3 , to control for tumor size when considering the effect of Ccn6 loss on metastasis. All mammary tumors were excised, weighed and collected for histology and RNA isolation as described elsewhere in the methods. Lungs were inflated with 10% neutral buffered formalin, macrometastases were counted immediately by eye, and then lobes were separated and placed in a cassette for histology.
MATERIALS AND METHODS

Genotyping
Mice and embryos were genotyped by PCR analysis of genomic DNA from mouse tail samples. Isolation of genomic DNA was done using the DNeasy Blood and Tissue Kit (Qiagen, Valencia, CA, USA, #69506) according to the manufacturer's instructions. Primers used to genotype CCN6 alleles were P1, 5′-TTC AAA ATT GTG GGA ATA GCT CCA GTA TT-3′; P2 5′-CC A TTG ATA CTG GTT GAG AAC ACA GTG AG-3′. Amplification with these primers results in a 196-bp fragment from the CCN6 WT allele and a 344-bp fragment from the CCN6 fl allele after neo deletion. Primers used to genotype CRE alleles were P1, 5′-GGT TCT GAT CTG AGC TCT GAG TG-3′; P2 5′-CAT CAC TCG TTG CAT CGA CCG G-3′. PCR was performed for 35 cycles of 94°C (30 s), 56°C (90 s) and 72°C (60 s) for amplification of Ccn6 and Cre alleles. 
Animal studies
All procedures were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at the University of Michigan (UCUCA #PRO00005009). Mice were housed in standard conditions, at 23°C, with a 14/10 h light/dark cycle, and food and water supplied ad libitum. We observed no difference among any of the control mice genotypes when considering histological and morphological phenotype, immunoblots or qPCR data; therefore, the wild-type control groups presented here consist of a mixture of all of the genotypes. Mice were euthanized and the left # 4 inguinal mammary gland was excised, spread onto a microscope slide and immediately fixed in Carnoy's fixative for 5 h. Subsequently, the tissue was washed in graded alcohol solutions (70, 50, 25%; 15 min each) and finally in ddH 2 O for 5 min. Staining was carried out overnight in carmine alum stain. The tissue was then dehydrated in graded alcohol solutions (70, 80, 95 and 100%; 15 min each), cleared in xylene overnight, and mounted using Permount. Whole mounts were observed under a Leica MZFL III Stereo/Dissecting microscope (Leica Microsystems GmbH, Wetzlar, Germany), and digital images were recorded using an Olympus DP-70 digital camera. A portion of the mammary gland was placed in a cassette and fixed in 10% neutral buffered formalin for 48 h at room temperature. After fixation, tissues were transferred to 70% ethanol, embedded in paraffin, sectioned and stained with hematoxylin and eosin for routine histological examination, or left unstained for later immunohistochemistry.
Microarray analysis and statistics
RNA was isolated from either 8-week-old knockout and control mouse mammary glands (n = 4 for each group), or mammary tumors from Ccn6 fl/fl ; MMTV-Cre mice and age matched Ccn6 wt/wt ;MMTV-Cre control mammary glands (n = 4 for each group). Isolated RNA was processed on a Mouse Gene ST 2.1 strip assay at the University of Michigan Microarray Core using the Affy Plus Kit (Affymetrix). For statistical analyses, robust multi-array average was used to fit log2 expression values to probesets using the oligo package of bioconductor. 49 Linear models were fit using the limma package of bioconductor to identify differentially expressed probesets. 50 Arrays were weighted based on a gene-by-gene update algorithm designed to downweight genes deemed less reproducible. 51 P-values were adjusted using false discovery rate. 52 Comparison to human metaplastic carcinoma was done using data from a custom Agilent array of 12 patient samples developed at the University of North Carolina, GEO# GSE10885. 5 The mouse Affymetrix array data were compared to the human Agilent array data to identify the matching gene symbols between the arrays; further, a list of the gene symbols that were significantly deregulated in the same direction in both arrays was compiled. Statistical analysis of the resulting contingency table was done using a Fisher's exact test.
Immunoblots
Whole mammary tissue sample (50 mg) was weighed from the most distal portion of the #4 inguinal mammary gland and lysed in RIPA lysis buffer (Thermo-Fisher Scientific, Waltham, MA, USA) with protease and phosphatase (Thermo-Fisher Scientific) inhibitors at 100 × dilution in Precellys 2 ml tissue homogenizing mixed beads kit (Cayman Chemical, Ann Arbor, MI, USA) using a Precellys homogenizer at 6500 rpm (2 cycles of 15 s motion − 15 s rest). Immunoblots were carried out with 40 μg of total protein. Membranes were blocked in Tris-buffered saline, 0.1% Tween 20 (TBS-T) (Bio-Rad, Philadelphia, PA, USA, with 0.05% Tween20) with 4% milk (Bio-Rad, #170-6404) and incubated with primary antibodies in TBS-T at 4°C overnight. Membranes were stained with Ponceau-S solution (Sigma-Aldrich, St Louis, MO, USA) to confirm equal loading. Anti-CCN6 (Santa Cruz Biotechnology, Santa Cruz, CA, USA, #SC-25443) was the primary antibody.
Immunohistochemical studies
Immunohistochemistry of human breast cancer tissue samples was performed in 110 cases of invasive breast carcinoma comprising 82 invasive ductal and 28 metaplastic carcinomas obtained with University of Michigan IRB approval (HUM00050330). Hematoxylin and eosin-stained samples were histologically evaluated and 5 μm thick sections were immunostained using anti-CCN6 (Santa Cruz Biotechnology) following published protocols. 9 CCN6 expression was evaluated as either low or high based on intensity of staining and percentage of cells staining. 9 To immunostain mouse mammary glands formalin-fixed, paraffinembedded sections were cut at 5 μm and rehydrated with water. Heat induced epitope retrieval was performed with FLEX TRS High pH Retrieval Buffer (9.01) for CCN6, for 20 min (Dako, Carpinteria, CA). Immunohistochemical staining was performed using Peroxidase for 5 min to quench endogenous peroxidases, followed by incubation for 60 min with one of the following antibodies: CCN6 (Santa Cruz Biotechnology), CK-18 (Abcam, Cambridge, MA, USA), E-cadherin (BD Biosciences, San Jose, CA, USA), Vimentin (BD Biosciences), CD10 (BD Biosciences), p63 (Santa Cruz Biotechnology), ERα (Santa Cruz Biotechnology) and HER-2/neu (Santa Cruz Biotechnology). The EnVision+Rabbit horseradish peroxidase System was used for detection (DakoCytomation, Santa Clara, CA, USA). 3,3'diaminobenzidine chromagen was then applied for 10 min. Slides were counterstained with hematoxylin for 5 s and then dehydrated and coverslipped. For quantification, three representative areas from three Ccn6 fl/fl ;MMTV-Cre and three Ccn6 wt/wt ;MMTV-Cre mice were counted for epithelial cells that stained positive for the protein of interest and calculated as a percentage of the total number of epithelial cells; all counts were done blind to genotype by two separate investigators.
Statistics
Data are expressed as mean ± s.d. All experiments were repeated at least three times with similar results. The two-tailed Student's t test was performed to determine the probability of statistically significant difference (P-values) and recorded in figure legends. A P-value less than 0.05 was considered statistically significant.
